Canvax Biotech
 |
||
Canvax is a leading manufacturer and supplier of the most innovative solutions, kits and R&D Reagents inside Molecular Biology fields. Since its foundation in 2001, Canvax offers reliable, cost-effective and easy-to-use innovative tools for research. Based in Córdoba (Spain), since its beginning it has focused on R&D of multiplex high throughput platforms (HTS) for Drug discovery and Diagnostic applied biosensors. Over a decade later, Canvax is a worldwide leading expert in GPCR expression in heterologous cells, with important patents and exclusive know-how. Canvax prides itself to be the first company to get an unprecedented milestone that could revolutionize the Diagnostics sector: Canvax established stable high-level expression of odour GPCRs into heterologous cell lines in 2014. This key milestone, that could be applied in diagnostic, perfume and cosmetic industry, are being employed to obtain a molecular nose, a sensitive and non-invasive diagnostic molecular device for early detection of cancer, as the nose of trained dogs do. Thanks to this project, Canvax was awarded, in 2013, with the largest Public & Private Contract for Pre competitive Technology Development in Spanish history. Website : www.lifescience.canvaxbiotech.com | ||
Recombinase expression plasmids
Recombinase expression plasmids are powerful tools in the field of molecular biology, offering researchers the ability to manipulate and edit genetic material with precision and efficiency. Recombinases are enzymes that are capable of recognizing specific DNA sequences and catalyzing the exchange of DNA segments between these sequences, allowing for the precise manipulation of genetic material.
In recent years, the development of recombinase expression plasmids has revolutionized the field of genetic engineering, enabling the creation of genetically modified organisms with unprecedented precision and control. These plasmids allow for the expression of recombinases in cells, allowing researchers to target specific genetic sequences for manipulation.
The development of recombinase expression plasmids has not only advanced the field of genetic engineering, but has also created new opportunities for marketing and commercialization of genetic engineering technologies. Companies are now offering recombinase expression plasmids as research tools to the scientific community, with the aim of advancing the understanding of genetics and the development of new therapeutics.
Ergebnis Ihrer Suche : 2 Produkt(e) gefunden
Grenzen Sie Ihre Suche ein :
- Unconjugated 2